packageIbrutinib

ibrutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ibrutinib is a Bruton's tyrosine kinase inhibitor used to treat B-cell blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma, and other lymphomas. It is an approved medicine, authorised in the European Union, and is widely used in oncology care.

Summary written by glm-5.3-flash from Wikidata Q5984881 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ibrutinib
ATC codes:L01EL01
DrugBank:DB09053
PubChem CID:24821094
ChEBI:76612
Wikidata:Q5984881
formula:C25H24N6O2
molar mass:440.507 g/mol (PubChem CID 24821094)
logP:3.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown